Pittsburgh-based Highmark Health, the nation’s second-largest integrated healthcare network based on revenue, is testing a virtual cardiac rehabilitation solution for delivering cardiac rehab remotely to patients with heart disease.
Early in 2019 Highmark transformed its VITAL Innovation Platform, which facilitates real-world testing of early-stage health innovations, from an internal platform to a commercial offering — meaning companies pay Highmark to test their products. Making VITAL a commercial offering helps it source new innovations and make the program a recognizable name out in the marketplace, the company said.
Through its VITAL platform, it is testing Moving Analytics’ MOVN virtual cardiac rehabilitation solution. “In support of Highmark Health’s mission to create a remarkable health experience, freeing people to be their best, VITAL continues to focus on major diseases and early-stage FDA-approved health innovations that show promise for improved diagnosis, treatment and return to better health,” said Anil Singh, M.D., Allegheny Health Network (AHN) and VITAL medical advisor, in a statement. “By testing MOVN, we’re studying a new cardiac rehabilitation delivery system that could significantly benefit our patients and the millions of Americans living with heart diseases.”